Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You would lose that bet Fbg.
Fed policy will not be helping shorts cover..strategy change coming
Spent the rest at 6.26..oh yes.
I just bought at 6.36..happy
who runs the company now? 25% short interest or 75% longs.we will soon know.
sounds good to me.
complete short manipulation of share price must end. the cause less relevant.
getting approval for treating specific cancer sub-types..also very importantly..validates the LM platform.. but our big pharma partners already are listening and looking..
too much personal sentiment attached..about 10 million short shares that need resolution before we go anywhere with s/p..
dan didn't even know they were unhappy..then again there was no need for him to know..i guess we will see the drama unfold in the coming days..except this is a terrible time to put on a show..may be that's why its happening now..when everyone is gone.
if adxs really has the ability to enhance other systems/treatments it would pay amgen, bmy, astra, merck to keep adxs as some utility from which they license adxs technology..or am i missing something.and i think we need to see a reduction in short interest before any s/p evaluation..maybe its already in the cards and needs to play out.?
interesting links published last week discussing the need for targeting delivery system to specific cancer geonome targets..LM makes it possible to engineer that..a big deal no doubt.. however it is not the only way..being to proprietary about its technology can kill a company..and rapidly isolate them to niche markets..
mpreorder..this makes sense to me too..non exclusive license to multiple partners makes the most sense..when and what to lease may be determined by a number of factors..but i got the feeling doc was not particularly flexible..
board members switched their allegiance quickly..must have been some compelling alternative that didn't include our CEO..
faced with needing 25% of the company just to cover..perhaps it is shorts who stole the company from dan by making their case to BOD..whatever that entailed..now they just issue themselves 10 million shares and on to part 2..
sell multiple copies of the LM platform
well it feels like tutes have taken over and will be taking a new management direction..as in don't let the door..so we will see..
i think there would be a huge investor lawsuit..further delaying the situation.
we have to get rid of short/s interest..what do you do when you need 25% of company stock just to cover..and how does management shed them..
stock2re one could argue Dan got to close to this..but who here hasn't..but delay has consequences in this fast moving cancer vaccine world..it works..
do we sell for less short term more longer term..nice choices to have..
very little after hours selling and no pre market according to nasdaq..don't see big short interest push anywhere..may be waiting for market open..but see no sentiment setting in pre market
congrads to doc..now for the rest of us whose timeline is already over extended..
if fgb is correct and short interest concern has been addressed with doc's departure..we will see share price go up sooner rather than later..change in direction..cashing in sooner rather than later, should attract wall street interest in an otherwise previously orphaned stock..
for sale sign in the front yard..buy out will also clear short shares from table..should be fun watching that..making adxs next big bio not in the cards..thats ok..now what is the new strategy/plan...good price..( circa 5 billion) ok by me....
doc failed to deal with concerns of massive short interest..may be that will happen now..may be it will be reflected in share holder value..he retained his vesting schedule..and will receive around 800,000 in cash.
tutes only need to recall loaned shares..
it makes sense to liscense the LM platform..rather than trying to make money from its products..
may be FBG was a messenger..
a new management is in place to complete liscensing of LM platform technology directly to end user needing a target system. I think dan would oppose that..and perferred to provide lm services..
I like the idea of merger to wipe out shorts..Dan gone because company is headed in very different direction..one to rid us of 10 million imaginary shares.
It was over a year long battle with shorts running the share price..nice merger could fix it over night..failure to take company from shorts and the fact it will take 25% of company shares just to cover may have done him in..Agree with poster..ignoring this ability of shorts to run the sp down at will was a telling indicator.
investor sentiment towards cancer vaccine development is about to change.
for shorts to cover..they must purchase 25% of adxs stock..
what would the price per share of adxs be if 10 million borrowed shares got recalled..that's the market value
i have learned you can not rely on momentum..either way..expensive but easy to manufacture.
adxs has carried 9-10 million balance of short shares for the last 12 months plus..and there have been lots of opp to cover..but shorts did not..like you said the short shares allow them to control the sp for now.tutes recalling the loaned shares is best direct way to end it. and they may do that if share demand increases overall..maybe another deal like the one with selene..or perhaps we target listeria to go after the newly found protein marker identifying hidden hiv infected cells..
There need to be real sellers for shorts to cover not just share exchange..this will end when owners recall..or of course sustainable price demand curve that finds home for newly shorted shares,which has happened, thus exacerbating the share deficit..and more pressure on shorts..tutes no doubt buying at these prices..same tutes who lent shares in the first place..anyone want to short at these prices..good demand for shares down here.
the fat lady is holding a concert in the next 30-60 days..she's being sponsored by some very optimistic financing..or you can worry about obtuse pfs conjectures and ignore the obvious..follow the money..not endless conjecture built upon endless assumptions.
i think we remain independent company..selling our constructs as franchises and possible distribute directly..what does that require..a postal service and a doctors office somewhere..doing our own distribution will be cheap..we are already working with major cancer centers..except for board fantasies I see no reason for a buy out and every reason to remain independent.